Nanostructured delivery system for Suberoylanilide hydroxamic acid against lung cancer cells
- 1 June 2015
- journal article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 51, 362-368
Abstract
No abstract availableKeywords
Funding Information
- University Grant Commission (UGC), Government of India (40-208/2011)
- Department of Science and Technology—Fund for Improvement of S & T Infrastructure in Universities and Higher Educational Institutions (DST-FIST) (SR/FST/LSI-075/2011)
This publication has 33 references indexed in Scilit:
- Epigenetic protein families: a new frontier for drug discoveryNature Reviews Drug Discovery, 2012
- Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapyOncogene, 2011
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdvanced Drug Delivery Reviews, 2011
- Poly(D,L-lactic-co-glycolic acid) Nanoencapsulation Reduces Erlotinib-Induced Subacute Toxicity in RatJournal of Biomedical Nanotechnology, 2009
- Development of vorinostat: Current applications and future perspectives for cancer therapyCancer Letters, 2009
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Histone AcetyltransferasesAnnual Review of Biochemistry, 2001
- Encapsulation of Hydrophilic and Lipophilic Drugs in PLGA Nanoparticles by the Nanoprecipitation MethodDrug Development and Industrial Pharmacy, 1999